Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Mesa Laboratories (MLAB) Cost of Revenue (2016 - 2025)

Mesa Laboratories' Cost of Revenue history spans 16 years, with the latest figure at $23.3 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 123.26% to $23.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.3 million, a 163.72% increase, with the full-year FY2025 number at $41.7 million, up 7.92% from a year prior.
  • Cost of Revenue hit $23.3 million in Q4 2025 for Mesa Laboratories, up from $9.8 million in the prior quarter.
  • Over the last five years, Cost of Revenue for MLAB hit a ceiling of $26.1 million in Q4 2021 and a floor of -$23.2 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $10.1 million across 5 years, with a median of $11.1 million in 2025.
  • The widest YoY moves for Cost of Revenue: up 448.47% in 2021, down 198.55% in 2021.
  • Tracing MLAB's Cost of Revenue over 5 years: stood at $26.1 million in 2021, then tumbled by 67.64% to $8.4 million in 2022, then skyrocketed by 137.89% to $20.1 million in 2023, then tumbled by 47.93% to $10.4 million in 2024, then skyrocketed by 123.26% to $23.3 million in 2025.
  • Business Quant data shows Cost of Revenue for MLAB at $23.3 million in Q4 2025, $9.8 million in Q3 2025, and $10.9 million in Q2 2025.